Molecular basis of P[II] major human rotavirus VP8* domain recognition of histo-blood group antigens.
Journal
PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
14
11
2019
accepted:
05
02
2020
revised:
03
04
2020
pubmed:
26
3
2020
medline:
23
6
2020
entrez:
26
3
2020
Statut:
epublish
Résumé
Initial cell attachment of rotavirus (RV) to specific cell surface glycan receptors, which is the essential first step in RV infection, is mediated by the VP8* domain of the spike protein VP4. Recently, human histo-blood group antigens (HBGAs) have been identified as receptors or attachment factors for human RV strains. RV strains in the P[4] and P[8] genotypes of the P[II] genogroup share common recognition of the Lewis b (Leb) and H type 1 antigens, however, the molecular basis of receptor recognition by the major human P[8] RVs remains unknown due to lack of experimental structural information. Here, we used nuclear magnetic resonance (NMR) spectroscopy-based titration experiments and NMR-derived high ambiguity driven docking (HADDOCK) methods to elucidate the molecular basis for P[8] VP8* recognition of the Leb (LNDFH I) and type 1 HBGAs. We also used X-ray crystallography to determine the molecular details underlying P[6] recognition of H type 1 HBGAs. Unlike P[6]/P[19] VP8*s that recognize H type 1 HBGAs in a binding surface composed of an α-helix and a β-sheet, referred as the "βα binding site", the P[8] and P[4] VP8*s bind Leb HBGAs in a previously undescribed pocket formed by the edges of two β-sheets, referred to as the "ββ binding site". Importantly, the P[8] and P[4] VP8*s retain binding capability to non-Leb type 1 HBGAs using the βα binding site. The presence of two distinct binding sites for Leb and non-Leb HBGA glycans in the P[8] and P[4] VP8* domains suggests host-pathogen co-evolution under structural and functional adaptation of RV pathogens to host glycan polymorphisms. Assessment and understanding of the precise impact of this co-evolutionary process in determining RV host ranges and cross-species RV transmission should facilitate improved RV vaccine development and prediction of future RV strain emergence and epidemics.
Identifiants
pubmed: 32208455
doi: 10.1371/journal.ppat.1008386
pii: PPATHOGENS-D-19-02135
pmc: PMC7122821
doi:
Substances chimiques
Capsid Proteins
0
Lewis Blood Group Antigens
0
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1008386Subventions
Organisme : NIAID NIH HHS
ID : R01 AI123661
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI130631
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Nat Commun. 2018 Jul 6;9(1):2631
pubmed: 29980685
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Adv Exp Med Biol. 2004;554:135-43
pubmed: 15384573
Nat Commun. 2015 Jan 05;6:5907
pubmed: 25556995
Nat Protoc. 2010 May;5(5):883-97
pubmed: 20431534
Clin Infect Dis. 2014 Dec 1;59(11):1567-73
pubmed: 25097083
Infect Immun. 2004 Jul;72(7):4279-81
pubmed: 15213174
PLoS One. 2013 Nov 11;8(11):e78113
pubmed: 24244290
Nature. 2012 Apr 15;485(7397):256-9
pubmed: 22504179
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Nat Chem Biol. 2009 Feb;5(2):91-3
pubmed: 19109595
J Virol. 2001 Mar;75(5):2276-87
pubmed: 11160731
Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):72-82
pubmed: 16369096
Vet Microbiol. 2016 Nov 30;196:27-35
pubmed: 27939152
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
J Biol Chem. 1981 Apr 10;256(7):3512-24
pubmed: 6782103
J Mol Biol. 2007 Apr 6;367(4):1215-26
pubmed: 17306299
Sci Rep. 2016 Oct 06;6:34591
pubmed: 27708367
Biosci Biotechnol Biochem. 2013;77(3):455-66
pubmed: 23470761
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
Clin Infect Dis. 2016 May 1;62 Suppl 2:S96-S105
pubmed: 27059362
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
pubmed: 15299926
Acta Crystallogr D Biol Crystallogr. 1999 Oct;55(Pt 10):1690-5
pubmed: 10531518
Emerg Infect Dis. 2015 Nov;21(11):2055-8
pubmed: 26488868
J Virol. 2013 Jul;87(13):7255-64
pubmed: 23616650
PLoS Pathog. 2019 Jun 21;15(6):e1007865
pubmed: 31226167
Clin Infect Dis. 2016 Jan 1;62(1):11-18
pubmed: 26508510
Lancet Infect Dis. 2014 Sep;14(9):847-56
pubmed: 25082561
Rev Med Virol. 2005 Jan-Feb;15(1):29-56
pubmed: 15484186
J Infect Dis. 2010 Sep 1;202 Suppl:S139-47
pubmed: 20684694
Prog Nucl Magn Reson Spectrosc. 2013 Aug;73:1-16
pubmed: 23962882
J Virol. 2012 May;86(9):4833-43
pubmed: 22345472
Infect Genet Evol. 2013 Jan;13:27-35
pubmed: 22982160
J Virol. 2015 Jan 15;89(2):1043-57
pubmed: 25378486
J Gen Virol. 2013 Jan;94(Pt 1):136-142
pubmed: 23052396
EMBO J. 2002 Mar 1;21(5):885-97
pubmed: 11867517
J Virol. 1999 Apr;73(4):3147-53
pubmed: 10074166
J Am Chem Soc. 2001 Jun 27;123(25):6108-17
pubmed: 11414845
F1000Res. 2016 Feb 18;5:189
pubmed: 26973785
Nat Commun. 2015 Sep 30;6:8346
pubmed: 26420502
Science. 1998 Jan 16;279(5349):373-7
pubmed: 9430586
J Biomol NMR. 1995 Nov;6(3):277-93
pubmed: 8520220
J Infect Dis. 2016 Oct 1;214(7):1039-49
pubmed: 27471320
J Mol Biol. 2016 Feb 22;428(4):720-725
pubmed: 26410586
Biochemistry. 1997 Nov 11;36(45):13882-9
pubmed: 9374866
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Virol Sin. 2019 Oct 16;:
pubmed: 31620994
J Infect Dis. 2010 Sep 1;202 Suppl:S23-33
pubmed: 20684708
J Mol Biol. 2011 Nov 11;413(5):929-39
pubmed: 21945555
J Infect Dis. 2016 Sep 1;214(5):732-8
pubmed: 27302190
PLoS Comput Biol. 2009 Mar;5(3):e1000307
pubmed: 19282963
Sci Rep. 2018 Aug 28;8(1):12961
pubmed: 30154494
Mol Cell Proteomics. 2014 Nov;13(11):2944-60
pubmed: 25048705
PLoS Pathog. 2017 Nov 14;13(11):e1006707
pubmed: 29136651
Vox Sang. 1989;56(1):1-20
pubmed: 2464874
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
J Virol. 2002 Apr;76(8):4087-95
pubmed: 11907248
Angew Chem Int Ed Engl. 1999 Jun 14;38(12):1784-1788
pubmed: 29711196
Emerg Microbes Infect. 2017 Apr 12;6(4):e22
pubmed: 28400594
Biochim Biophys Acta. 1999 Dec 6;1473(1):247-66
pubmed: 10580143
PLoS One. 2015 Aug 14;10(8):e0134584
pubmed: 26274396
J Virol. 2012 Sep;86(18):9899-910
pubmed: 22761376
Virus Res. 2016 Jan 4;211:64-8
pubmed: 26454189
J Infect Dis. 2010 Sep 1;202 Suppl:S34-42
pubmed: 20684715
Rev Bras Hematol Hemoter. 2016 Oct - Dec;38(4):331-340
pubmed: 27863762
J Infect Dis. 2018 Apr 11;217(9):1399-1407
pubmed: 29390150
J Pediatr. 2006 Oct;149(4):448-51
pubmed: 17011312
J Chem Inf Model. 2011 Oct 24;51(10):2778-86
pubmed: 21919503
Emerg Infect Dis. 2006 Feb;12(2):304-6
pubmed: 16494759
J Virol. 2009 Apr;83(7):2917-29
pubmed: 19153225
Virology. 1991 Apr;181(2):553-63
pubmed: 1849677
J Virol. 2018 Jun 29;92(14):
pubmed: 29720519
J Infect Dis. 2014 Apr 15;209(8):1227-30
pubmed: 24277741
J Infect Dis. 2017 Mar 1;215(5):786-789
pubmed: 28329092
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Lancet Infect Dis. 2012 Feb;12(2):136-41
pubmed: 22030330
J Virol. 2016 Oct 14;90(21):9983-9996
pubmed: 27558427
J Am Chem Soc. 2003 Feb 19;125(7):1731-7
pubmed: 12580598
Trends Microbiol. 2011 Aug;19(8):382-8
pubmed: 21705222